Literature DB >> 24471047

The impact factors on 5-year survival rate in patients operated with oral cancer.

Dong-Ho Geum1, Young-Chea Roh1, Sang-Yong Yoon1, Hyo-Geon Kim1, Jung-Han Lee1, Jae-Min Song1, Jae-Yeol Lee1, Dae-Seok Hwang1, Yong-Deok Kim1, Sang-Hun Shin1, In-Kyo Chung1, Uk-Kyu Kim1.   

Abstract

OBJECTIVES: The purpose of this study is to analyze clinical impact factors on the survival rate, and to acquire basic clinical data for the diagnosis of oral cancer, for a determination of the treatment plan with long-term survival in oral cancer patients.
MATERIALS AND METHODS: Through a retrospective review of the medical records, the factors for long-term survival rate were analyzed. Thirty-seven patients, among patient database with oral cancer treated in the Department of Oral and Maxillofacial Surgery at Pusan National University Hospital within a period from March 1998 to March 2008, were selected within the study criteria and were followed-up for more than 5 years. The analyzed factors were gender, age, drinking, smoking, primary tumor site, type of cancer, TNM stage, recurrence of affected region, and metastasis of cervical lymph node. The 5-year survival rate on the impact factors was calculated statistically using the Kaplan-Meier method.
RESULTS: By classification of clinical TNM at the 1st visit, there were 11 (29.7%) cases for stage I, 11 (29.7%) cases for stage II, 3 (8.1%) cases for stage III, and 12 (32.5%) cases for stage IV. The 5-year survival rate of total oral cancer patients after the operation were 75.7%, pathological TNM stage related 5-year survival rate were as follows: stage I 90.0%, stage II 81.8%, stage III 100% and stage IV 45.5%; in which the survival rate difference by each stage was significantly observed. The recurrence of cervical lymph node was the significant impact factor for the survival rate, because only 30.0% the survival rate in recurrent cases existed. During the follow-up, there were 15 (40.5%) patients with confirmed recurrence, and the 5-year survival rate of these patients was decreased as 46.7%.
CONCLUSION: The classification of clinical and pathological TNM stage, local recurrence after surgery, and metastasis of cervical lymph node after surgery were analyzed as the 3 most significant factors.

Entities:  

Keywords:  Neoplasm metastasis; Oral cancer; Recurrence; Survival rate; TNM classification

Year:  2013        PMID: 24471047      PMCID: PMC3858143          DOI: 10.5125/jkaoms.2013.39.5.207

Source DB:  PubMed          Journal:  J Korean Assoc Oral Maxillofac Surg        ISSN: 1225-1585


  23 in total

1.  Elective neck dissection for carcinomas of the oral cavity: occult metastases, neck recurrences, and adjuvant treatment of pathologically positive necks.

Authors:  Peter Zbären; Michel Nuyens; Marco Caversaccio; Edouard Stauffer
Journal:  Am J Surg       Date:  2006-06       Impact factor: 2.565

2.  Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection.

Authors:  J A Woolgar; S Rogers; C R West; R D Errington; J S Brown; E D Vaughan
Journal:  Oral Oncol       Date:  1999-05       Impact factor: 5.337

3.  Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts.

Authors:  R Lindberg
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

4.  Intraoral squamous cell carcinoma. Epidemiologic patterns in Connecticut from 1935 to 1985.

Authors:  J K Chen; R V Katz; D J Krutchkoff
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

5.  The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.

Authors:  C J O'Brien; S J Traynor; E McNeil; J D McMahon; J M Chaplin
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-03

Review 6.  Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment.

Authors:  Missak Haigentz; Dana M Hartl; Carl E Silver; Johannes A Langendijk; Primož Strojan; Vinidh Paleri; Remco de Bree; Jean-Pascal Machiels; Marc Hamoir; Alessandra Rinaldo; Daniela Paccagnella; Ashok R Shaha; Robert P Takes; Alfio Ferlito
Journal:  Oral Oncol       Date:  2012-04-18       Impact factor: 5.337

7.  The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: a prospective study in Spain.

Authors:  M Sandoval; R Font; M Mañós; M Dicenta; M J Quintana; F X Bosch; X Castellsagué
Journal:  Int J Oral Maxillofac Surg       Date:  2008-10-31       Impact factor: 2.789

Review 8.  Natural history of potentially malignant oral lesions and conditions: an overview of the literature.

Authors:  Séamus S Napier; Paul M Speight
Journal:  J Oral Pathol Med       Date:  2008-01       Impact factor: 4.253

9.  Risk factors for oral and pharyngeal cancer in young adults.

Authors:  Teresa Rodriguez; Andrea Altieri; Liliane Chatenoud; Silvano Gallus; Cristina Bosetti; Eva Negri; Silvia Franceschi; Fabio Levi; Renato Talamini; Carlo La Vecchia
Journal:  Oral Oncol       Date:  2004-02       Impact factor: 5.337

Review 10.  Oral cancer.

Authors:  Deepak Kademani
Journal:  Mayo Clin Proc       Date:  2007-07       Impact factor: 7.616

View more
  22 in total

1.  Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery.

Authors:  Manupol Tangthongkum; Virat Kirtsreesakul; Pasawat Supanimitjaroenporn; Peesit Leelasawatsuk
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-20       Impact factor: 2.503

2.  Neck dissection for oral squamous cell carcinoma: our experience and a review of the literature.

Authors:  Pooja Rani; Yogesh Bhardwaj; Praveen Kumar Dass; Manoj Gupta; Divye Malhotra; Narottam Kumar Ghezta
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2015-12-17

3.  C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma.

Authors:  Heung-Chul Park; Moon-Young Kim; Chul-Hwan Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-10-25

4.  Low Survival Rates of Oral and Oropharyngeal Squamous Cell Carcinoma.

Authors:  Anna Carolina Omena Vasconcellos Le Campion; Camila Maria Beder Ribeiro; Ronir Raggio Luiz; Francisco Feliciano da Silva Júnior; Herbert Charles Silva Barros; Karine de Cássia Batista Dos Santos; Stefania Jeronimo Ferreira; Lucio Souza Gonçalves; Sonia Maria Soares Ferreira
Journal:  Int J Dent       Date:  2017-05-30

5.  Overall and disease-specific survival outcomes following primary surgery for oral squamous cell carcinoma: analysis of consecutive 67 patients.

Authors:  Yookyeong Carolyn Sim; Jong-Hyun Hwang; Kang-Min Ahn
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2019-04-29

6.  Cytokeratins (CK7 and CK20) Genes Expression Association with Clinicopathological Indices in Oral Squamous Cell Carcinoma and Dysplastic Oral Epithelium.

Authors:  Mehdi Shahabinejad; Reza Zare; Farnaz Mohajertehran; Atefeh Amouzad Mahdiraji
Journal:  Rep Biochem Mol Biol       Date:  2021-04

7.  Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis.

Authors:  Jasdeep Kaur; Reinhilde Jacobs
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2015-08-21

8.  Muscular invasion by oral squamous cell carcinoma of the posterior mandibular alveolar ridge is associated with cervical lymph node metastasis.

Authors:  Seung-Ki Min; Hoon Myoung; Jong-Ho Lee; Myung-Jin Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-06-27

9.  Retrospective study on factors affecting the prognosis in oral cancer patients who underwent surgical treatment only.

Authors:  Byeong-Guk Kim; Jun-Hwa Kim; Myung-In Kim; Jeong Joon Han; Seunggon Jung; Min-Suk Kook; Hong-Ju Park; Sun-Youl Ryu; Hee-Kyun Oh
Journal:  Maxillofac Plast Reconstr Surg       Date:  2016-01-16

10.  Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer.

Authors:  Josephraj Sophia; Jaganathan Kowshik; Anju Dwivedi; Sujit K Bhutia; Bramanandam Manavathi; Rajakishore Mishra; Siddavaram Nagini
Journal:  Cell Death Dis       Date:  2018-10-23       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.